FOLFIRINOX vs gem/pac in the elderly: Is the survival benefit worth the risk?
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: SUNY Upstate Medical University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162684145
Cites:
Cited by:
Related to:
